Endogenous opioids and feeding behavior: A 30-year historical perspective

Peptides

Volumn 25, Issue 4, 2004, Pages 697-725

  Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

2 deoxy D glucose; 2DG; Agouti gene related peptide; AGRP; alpha melanocyte stimulating hormone; AMSH; ANG; angiotensin; antisense oligodeoxynucleotide; AS ODN; BCNA; BEND; beta chlornaltrexamine; beta endorphin; beta funaltrexamine; BFNA; BNST

Indexed keywords

AMPHETAMINE; BREMAZOCINE; BUPRENORPHINE; BUTORPHANOL; CATHINONE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DIAMORPHINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; FLUPENTIXOL; ICI174864; ICS205930; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; KETAZOCINE; LEUMORPHIN; LY255582; METHADONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; N ALLYLNORMETAZOCINE; NALOXONAZINE; NALOXONE; NALTREXONE; NALTRINDOLE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OXYTOCIN; SACLOFEN; SCH23390; SEROTONIN 1 ANTAGONIST; SKF38393; TIFLUADOM; U50488H; UNCLASSIFIED DRUG; UNINDEXED DRUG;

DRUG MECHANISM; FEEDING BEHAVIOR; FOOD INTAKE; INGESTION; MODULATION; NEUROSCIENCE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW;

ANIMALS; APPETITE REGULATION; FEEDING BEHAVIOR; HISTORY, 20TH CENTURY; HUMANS; MICE; MICE, TRANSGENIC; NARCOTIC ANTAGONISTS; OBESITY; OPIOID PEPTIDES; RECEPTORS, OPIOID;

AGOUTI;

EID: 2542460126     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.01.006     Document Type: Review

References (537)

1. Abbadie C., Pan Y.X., Drake C.T., Pasternak G.W. Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat. CNS Neurosci. 100:2000;141-153
2. Abbadie C., Pan Y.X., Pasternak G.W. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: evidence for region-specific processing. J. Comp. Neurol. 419:2000;244-256
3. Abbadie C., Pasternak G.W. Differential in vivo internalization of MOR-1 and MOR-1C by morphine. Neuroreport. 12:2001;3069-3072
4. Abbadie C., Pasternak G.W., Aicher S.A. Presynaptic localization of the carboxy terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience. 106:2001;833-842
5. Abrahamsen G.C., Berman Y., Carr K.D. Curve-shift analysis of self-stimulation in food restricted rats: relationship between daily meal, plasma corticosterone and reward sensitization. Brain Res. 695:1995;186-194
6. Ackerman T.F., Lamonte N., Bodnar R.J. Lack of intersite GABA receptor subtype antagonist effects upon mu opioid receptor agonist-induced feeding elicited from either the ventral tegmental area or nucleus accumbens shell in rats. Physiol. Behav. 79:2003;191-198
7. Agmo A., Galvan A., Talamantes B. Reward and reinforcement produced by drinking sucrose: two processes that may depend on different neurotransmitters. Pharmacol. Biochem. Behav. 52:1995;403-414
8. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7:1984;223-255
9. Antelman S.M., Rowland N. Endogenous opiates and stress-induced feeding. Science. 214:1981;1149
10. Apfelbaum M., Mandenoff A. Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol. Biochem. Behav. 15:1981;89-91
11. Appleyard S.M., Haywood M., Young J.I., Butler A.A., Cone R.D., Rubinstein M., et al. A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology. 144:2003;1753-1760
12. Aravich P.F., Rieg T.S., Lauterio T.J., Doerries L.E. Beta-endorphin and dynorphin abnormalities in rats subjected to exercise and restricted feeding: relationship to anorexia nervosa? Brain Res. 622:1993;1-8
13. Arjune D., Bodnar R.J. Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine. Brain Res. 534:1990;313-316
14. Arjune D., Bowen W.D., Bodnar R.J. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor. Pharmacol. Biochem. Behav. 39:1991;429-436
15. Arjune D., Standifer K.M., Pasternak G.W., Bodnar R.J. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535:1990;101-109
16. Atkinson R.L., Berke L.K., Drake C.R., Bibbs M.L., Williams F.L., Kaiser D.L. Effects of long-term therapy with naltrexone on body weight in obesity. Clin. Pharmacol. Ther. 38:1985;419-422
17. Azzara A.V., Bodnar R.J., Delamater A.R., Sclafani A. Naltrexone fails to block the acquisition or expression of a flavor preference conditioned by intragastric carbohydrate infusions. Pharmacol. Biochem. Behav. 67:2000;545-557
18. Badiani A., Leone P., Noel M.B., Stewart J. Ventral tegmental area opioid mechanisms and modulation of ingestive behavior. Brain Res. 670:1995;264-276
19. Badiani A., Stewart J. Enhancement of the prophagic but not of the antidipsogenic effect of U-50488H after chronic amphetamine. Pharmacol. Biochem. Behav. 44:1993;77-86
20. Bakshi V.P., Kelley A.E. Feeding induced by opioid stimulation of the ventral striatum: role of opioid receptor subtypes. J. Pharmacol. Exp. Ther. 265:1993;1253-1260
21. Bakshi V.P., Kelley A.E. Striatal regulation of morphine-induced hyperphagia: an anatomical mapping study. Psychopharmacology. 111:1993;207-214
22. Bakshi V.P., Kelley A.E. Sensitization and conditioning of feeding following multiple morphine microinjections into the nucleus accumbens. Brain Res. 648:1994;342-346
23. Baldwin B.A., de la Riva C., Ebenezer I.S. Effects of intracerebroventricular injection of dynorphin, leumorphin and alpha neo-endorphin on operant feeding in pigs. Physiol. Behav. 48:1990;821-824
24. Bare L.A., Mansson E., Yang D. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354:1994;213-216
25. Barnes M.J., Lapanowski K., Conley A., Rafols J.A., Jen K.L., Dunbar J.C. High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors. Brain Res. Bull. 61:2003;511-519
26. Barton C., Lin L., York D.A., Bray G.A. Differential effects of enterostatin, galanin and opioids on high-fat diet consumption. Brain Res. 702:1995;55-60
27. Barton C., York D.A., Bray G.A. Opioid receptor subtype control of galanin-induced feeding. Peptides. 17:1996;237-240
28. Basso A.M., Kelley A.E. Feeding induced by GABAA receptor stimulation within the nucleus accumbens shell: regional mapping and characterization of macronutrient and taste preference. Behav. Neurosci. 113:1999;324-336
29. Bauche F., Sabourault D., Giudicelli Y., Nordmann J., Nordmann R. 2-Mercaptoacetate administration depresses the beta-oxidation pathway through an inhibition of long-chain acyl-CoA dehydrogenase activity. Biochem. J. 196:1981;803-809
30. Bechara A., van der Kooy D. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats. Behav. Neurosci. 106:1992;351-363
31. Beczkowska I.W., Bodnar R.J. Mediation of insulin hyperphagia by specific central opiate receptor antagonists. Brain Res. 547:1991;315-318
32. Beczkowska I.W., Bodnar R.J. Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake. Pharmacol. Biochem. Behav. 38:1991;605-610
33. Beczkowska I.W., Bowen W.D., Bodnar R.J. Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589:1992;291-301
34. Beczkowska I.W., Koch J.E., Bodnar R.J. Naltrexone, serotonin receptor subtype antagonists and glucorprivic intake. I. 2-Deoxy-D-glucose. Pharmacol. Biochem. Behav. 42:1992;661-669
35. Beczkowska I.W., Koch J.E., Bostock M.E., Leibowitz S.F., Bodnar R.J. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res. 618:1993;261-270
36. Berman Y., Devi L., Carr K.D. Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions. Brain Res. 664:1994;49-53
37. Berman Y., Devi L., Carr K.D. Effects of streptozotocin-induced diabetes on prodynorphin-derived peptides in rat brain regions. Brain Res. 685:1995;129-134
38. Berman Y., Devi L., Spangler R., Kreek M.J., Carr K.D. Chronic food restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA levels in rat brain regions. Mol. Brain Res. 46:1997;25-30
39. Bertiere M.C., Mame Sy T., Baigts F., Mandenoff A., Apfelbaum M. Stress and sucrose hyperphagia: role of endogenous opiates. Pharmacol. Biochem. Behav. 20:1984;675-679
40. Bertino M., Abelson M.L., Marglin S.H., Neuman R., Burkhardt C.A., Reid L.D. A small dose of morphine increases intake of and preference for isotonic saline among rats. Pharmacol. Biochem. Behav. 29:1988;617-623
41. Bhakthavatsalam P., Leibowitz S.F. Morphine-elicited feeding: diurnal rhythm, circulating corticosterone and macronutrient selection. Pharmacol. Biochem. Behav. 24:1986;911-917
42. Billington C.J., Herman B.H., Bartness T.J., Levine A.S., Morley J.E. Effects of the opiate antagonists diprenorphine and naloxone and of selected opiate agonists on feeding behavior in guinea pigs. Life Sci. 46:1990;147-154
43. Billington C.J., Morley J.E., Levine A.S., Gerritsen C.G. Feeding systems in Chinese hamsters. Am. J. Physiol. 247:1984;R405-R411
44. Billington C.J., Morley J.E., Levine A.S., Wright F., Seal U.S. Naloxone induced suppression of feeding in tigers. Physiol. Behav. 34:1985;641-643
45. Birch P.J., Hayes A.G., Sheehan M.J., Tyers M.B. Norbinaltorphamine antagonist profile at kappa receptors. Eur. J. Pharmacol. 144:1987;405-408
46. Bodnar R.J., Glass M.J., Koch J.E. Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats. Brain Res. Bull. 36:1995;293-300
47. Bodnar R.J., Glass M.J., Ragnauth A., Cooper M.L. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 700:1995;205-212
48. Bodnar R.J., Hadjimarkou M.M., Krzanowska E.K., Silva R.M., Stein J.A. Differential dose-dependent effects of central morphine treatment upon food intake in male and female rats receiving neonatal hormone manipulations. Nutr. Neurosci. 6:2003;53-57
49. Boghossian S., Jourdan D., Dacher M., Alliot J. Effect of morphine on caloric intake and macronutrient selection in male and female Lou/c/jall rats during ageing. Mech. Ageing Dev. 122:2001;1825-1839
50. Bowen W.D., Hellewell S.B., Kelemen M., Huey R., Steward D. Affinity labelling of delta-opiate receptors using [D-Ala-2, Leu-5, Cys-6]-enkephalin: covalent attachment via thiosulfide exchange. J. Biol. Chem. 262:1987;13434-13439
51. Bozarth M.A., Wise R.A. Intracranial self-administration pf morphine into the ventral tegmental area. Life Sci. 28:1981;551-555
52. Brands B.J., Thornhill J.A., Hirst M., Gowdey C.W. Suppression of food intake and body weight by naloxone in rats. Life Sci. 24:1979;1773-1778
53. Brewerton T.D., Lydiard R.B., Laraia M.T., Shook J.E., Ballenger J.C. CSF beta-endorphin and dynorphin in Bulimia Nervosa. Am. J. Psychiat. 149:1992;1086-1090
54. Brown D.R., Blank M.S., Holtzman S.G. Suppression by naloxone of water intake induced by deprivation and hypertonic saline in intact and hypophysectomized rats. Life Sci. 26:1980;1535-1542
55. Brown D.R., Holtzman S.G. Evidence that opiate receptors mediate suppression of hypertonic saline-induced drinking in the mouse by narcotic antagonists. Life Sci. 26:1980;1543-1550
56. Brown D.R., Holtzman S.G. Opiate antagonists: central sites of action in suppressing water intake of the rat. Brain Res. 221:1981;432-436
57. Brown D.R., Holtzman S.G. Suppression of drinking by naloxone in the rat: a further characterization. Eur. J. Pharmacol. 69:1981;331-340
58. Brown D.R., Holtzman S.J. Suppression of deprivation induced food and water intake in rats and mice by naloxone. Pharmacol. Biochem. Behav. 11:1979;567-583
59. Brugman S., Clegg D.J., Woods S.C., Seeley R.J. Combined blockade of both micro- and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein. Endocrinology. 143(11):2002;4265-4270
60. Burdick K., Yu W.-Z., Ragnauth A., Moroz M., Pan Y.X., Rossi G.C., et al. Antisense mapping of opioid receptor clones: effects upon 2-deoxy-D-glucose- induced hyperphagia. Brain Res. 794:1998;359-363
61. Cador M., Kelley A.E., LeMoal M., Stinus L. Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience. 18:1986;659-669
62. Calcagnetti D.J., Calcagnetti R.L., Fanselow M.S. Centrally administered opioid antagonists nor-binaltorphamine, 16-methyl cyrenorphine and MR2266 suppress intake of a sweet solution. Pharmacol. Biochem. Behav. 35:1990;69-73
63. Calcagnetti D.J., Reid L.D. Morphine and acceptability of putative reinforcers. Pharmacol. Biochem. Behav. 18:1983;567-569
64. Carr K.D. Effects of antibodies to dynorphin A and beta-endorphin on lateral hypothalamic self-stimulation in ad libitum fed and food-deprived rats. Brain Res. 534:1990;8-14
65. Carr K.D. Streptozotocin-induced diabetes produces a naltrexone- reversible lowering of threshold for lateral hypothalamic self-stimulation. Brain Res. 664:1994;211-214
66. Carr K.-D., Aleman D.O., Bak T.H., Simon E.J. Effects of parabrachial opioid antagonism on stimulation-induced feeding. Brain Res. 545:1991;283-286
67. Carr K.D., Bak T.H. Rostral and caudal ventricular infusion of antibodies to dynorphin A (1-17) and dynorphin A (1-8): effects on electrically-elicited feeding in the rat. Brain Res. 507:1990;289-294
68. Carr K.D., Bak T.H., Gioannini T.L., Simon E.J. Antibodies to dynorphin A(1-13) but not beta-endorphin inhibit electrically-elicited feeding in the rat. Brain Res. 422:1987;384-388
69. Carr K.D., Bak T.H., Simon E.J., Portoghese P.S. Effects of the selective K opioid antagonist, nor-binaltorphamine, on electrically-elicited feeding in the rat. Life Sci. 45:1989;1787-1792
70. Carr K.D., Kutchukhidze N., Park T.H. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res. 822:1999;34-42
71. Carr K.D., Papadouka V. The role of multiple opioid receptors in the potentiation of reward by food restriction. Brain Res. 639:1994;253-260
72. Carr K.D., Papadouka V., Wolinsky T.D. Norbinaltorphamine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation. Psychopharmacology. 111:1993;345-350
73. Carr K.D., Park T.H., Stone E.A. Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats. Brain Res. 779:1998;26-32
74. Carr K.D., Simon E.J. Effects of naloxone and its quaternary analogue on stimulation-induced feeding. Neuropharmacology. 22:1983;127-130
75. Carr K.D., Simon E.J. Potentiation of reward by hunger is opioid mediated. Brain Res. 297:1984;369-373
76. Carr K.D., Wolinsky T.D. Chronic food restriction and weight loss produce opioid facilitation of perifornical hypothalamic self-stimulation. Brain Res. 607:1993;141-148
77. Carr K.D., Wolinsky T.D. Regulation of feeding by multiple opioid receptors in cingulate cortex, follow-up to an in vivo autoradiographic study. Neuropeptides. 26:1994;207-213
78. Chance W.T., Rosecrans J.A. Inhibition of drinking by intrahypothalamic administration of morphine. Nature. 270:1977;167-168
79. Churchill L., Bourdelais A., Austin M., Zahm D.S., Kalivas P.W. Gamma-aminobutyric acid and mu-opioid receptor localization and adaptation in the basal forebrain. Adv. Exp. Med. Biol. 295:1991;101-117
80. Churchill L., Kalivas P.W. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse. 11:1992;47-57
81. Churchill L., Kalivas P.W. A topographically organized gamma-aminobutyric acid projection from the ventral pallidum to the nucleus accumbens. J. Comp. Neurol. 345:1994;579-595
82. Ciccocioppo R., Biondini M., Antonelli L., Wichmann J., Jenck F., Massi M. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro64-6198. Psychopharmacology. 161(2):2002;113-119
83. Ciccocioppo R., Fedeli A., Economidou D., Plicani F., Weiss F., Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J. Neurosci. 23:2003;9445-9451
84. Ciccocioppo R., Martin-Fardon R., Weiss F., Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport. 12:2001;1145-1149
85. Clark J.A., Liu L., Price M., Hersh B., Edelson M., Pasternak G.W. Kappa opiate receptor multiplicity: evidence for two U50488H-sensitive K-1 subtypes and a novel K-3 subtype. J. Pharmacol. Exp. Ther. 251:1989;461-468
86. Clarke S.N., Parker L.A. Morphine-induced modification of quinine palatability: effects of multiple morphine-quinine trials. Pharmacol. Biochem. Behav. 51:1995;505-508
87. Clarkson D.B., King B.M., Hemmer R.C., Olson G.A., Kastin A.J., Olson R.D. Naloxone decreases consumption of liquid and solid sucrose in vagotomized rats. Physiol. Behav. 29:1982;927-930
88. Cleary J., Weldon D.T., O'Hare E., Billington C.J., Levine A.S. Naloxone effects on sucrose-motivated behavior. Psychopharmacology. 126:1996;110-114
89. Clegg D.J., Air E.L., Woods S.C., Seeley R.J. Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid-mediated. Endocrinology. 143:2002;2995-3000
90. Cohen M.L., Shuman R.T., Osborne J.J., Gesellchen P.D. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217. J. Pharmacol. Exp. Ther. 238:1986;769-772
91. Cole J.L., Berman N., Bodnar R.J. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats. Peptides. 18:1997;1201-1207
92. Cole J.L., Leventhal L., Pasternak G.W., Bowen W.D., Bodnar R.J. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678:1995;168-176
93. Cole J.L., Ross A., Bodnar R.J. Dietary history affects the potency of chronic opioid receptor subtype antagonist effects upon body weight in rats. Nutr. Neurosci. 1:1999;405-418
94. Conover K.L., Shizgal P. Competition and summation between rewarding effects of sucrose and lateral hypothalamic stimulation in the rat. Behav. Neurosci. 108:1994;537-548
95. Cooper S.J. Naloxone: effects on food and water consumption in the non-deprived and deprived rat. Psychopharmacology. 71:1980;1-6
96. Cooper S.J. Behaviorally-specific hyperdipsia in the non-dependent rat following acute morphine treatment. Neuropharmacology. 20:1981;469-472
97. Cooper S.J. Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat. Neuropharmacology. 22:1983;323-328
98. Cooper S.J., Barber D.J., Barber-Mcmullen J. Selective attenuation of sweetened milk consumption by opiate receptor antagonists in male and female rats of the Roman strains. Neuropeptides. 5:1985;349-352
99. Cooper S.J., Gilbert D.B. Naloxone suppresses fluid consumption in tests of choice between sodium chloride solutions and water in male and female water-deprived rats. Psychopharmacology. 84:1984;362-367
100. Cooper S.J., Jackson A., Kirkham T.C. Endorphins and food intake: K opioid receptor agonists and hyperphagia. Pharmacol. Biochem. Behav. 23:1985;889-901
101. Cooper SJ, Jackson A, Kirkham TC, Turkish S. Endorphins, opiates and food intake. In: Rodgers RJ, Cooper SJ, editors. Endorphins, opiates and behavioral processes. New York: Wiley, 1988. p. 143-86.
102. Cooper S.J., Jackson A., Morgan R., Carter R. Evidence for opiate receptor involvement in the consumption of a high palatability diet in non-deprived rats. Neuropeptides. 5:1985;345-348
103. Cooper S.J., Moores W.R., Jackson A., Barber D.J. Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists. Neuropharmacology. 24:1985;877-883
104. Cooper S.J., Turkish S. Effects of naloxone and its quartenary analogue on fluid consumption in water deprived rats. Neuropharmacology. 22:1983;797-800
105. Cotton R., Giles M.G., Miller L., Shaw J.S., Timms D. ICI 174864: a highly selective antagonist for the opioid delta receptor. Eur. J. Pharmacol. 97:1984;331-332
106. Cunningham S.T., Kelley A.E. Evidence for opiate-dopamine cross-sensitization in the nucleus accumbens: studies of conditioned reward. Brain Res. Bull. 29:1992;675-680
107. Curran E.J., Watson S.J. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361:1995;57-76
108. Czech D.A., Blake M.J., Stein E.A. Drinking behavior is modulated by CNS administration of opioids. Appetite. 5:1984;15-24
109. Czech D.A., Stein E.A. Naloxone suppresses osmoregulatory drinking in rats. Pharmacol. Biochem. Behav. 12:1980;987-989
110. Czech D.A., Stein E.A., Blake M.J. Naloxone-induced hypodipsia: a CNS mapping study. Life Sci. 33:1983;797-803
111. Czirr S.A., Reid L.D. Demonstrating morphine's potentiating effects on sucrose intake. Brain Res. Bull. 17:1986;639-642
112. DeCaro G., Micossi L.G., Venturi F. Drinking behavior induced by intracerebroventricular enkephalins in rats. Nature. 277:1979;51-53
113. Delamater A.R., Sclafani A., Bodnar R.J. Pharmacology of sucrose-reinforced place preference conditioning: effects of naltrexone. Pharmacol. Biochem. Behav. 65:2000;697-704
114. DePedro N., Cespedes M.V., Delgado M.J., Alonso-Bedate M. Mu-opioid receptor is involved in beta-endorphin-induced feeding in goldfish. Peptides. 17:1996;421-424
115. DePedro N., Delgado M.J., Alonso-Bedate M. Central administration of beta-endorphin increases food intake in goldfish: pretreatment with the opioid antagonist, naloxone. Regul. Peptides. 55:1995;189-195
116. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266:1993;1236-1246
117. Devine D.P., Leone P., Wise R.A. Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur. J. Pharmacol. 243:1993;55-64
118. Devine D.P., Wise R.A. Self-administration of morphine, DAMGO and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14:1994;1978-1984
119. DiChiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080
120. Doyle T.G., Berridge K.C., Gosnell B.A. Morphine enhances hedonic taste palatability in rats. Pharmacol. Biochem. Behav. 46:1993;745-749
121. Drewnowski A., Krahn D.D., Demitrack M.A., Nairn K., Gosnell B.A. Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol. Behav. 51:1992;371-379
122. Druhan J.P., Deschamps S.-E., Stewart J. D-Amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbens. Behav. Brain Res. 59:1993;41-51
123. Echo J.A., Lamonte N., Ackerman T.F., Bodnar R.J. Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of rats. Physiol. Behav. 76:2002;107-116
124. Echo J.A., Lamonte N., Christian G., Znamensky V., Ackerman T.F., Bodnar R.J. Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists. Brain Res. 921:2001;86-97
125. Evans C., Keith D., Morrison H., Magendzo K., Edwards R. Cloning of a delta-opioid receptor by functional expression. Science. 258:1992;1952-1955
126. Evans K.R., Vaccarino F.J. Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms. Neurosci. Biobehav. Rev. 14:1990;9-22
127. Fantino M., Brinnel H. Body weight set-point changes during the ovarian cycle: experimental study of rats using hoarding behavior. Physiol. Behav. 36:1986;991-996
128. Fernandez-Tome M.P., Gonzalez Y., DelRio J. Interactions between opioid agonists or naloxone and 5-HTP on feeding behavior in food-deprived rats. Pharmacol. Biochem. Behav. 29:1988;387-392
129. Fletcher P.J. Opiate antagonists inhibit feeding induced by 8-OH-DPAT: possible mediation in the nucleus accumbens. Brain Res. 560:1991;260-267
130. Frenk H., Rogers G.H. The suppressant effects of naloxone on food and water intake in the rat. Behav. Neur. Biol. 26:1979;23-40
131. Gaiardi M., Bartoletti M., Bacchi A., Gubellini C., Babbini M. Increased sensitivity to the stimulus properties of morphine in food-deprived rats. Pharmacol. Biochem. Behav. 26:1987;719-723
132. Giraudo S.Q., Billington C.J., Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat. Brain Res. 782:1998;18-23
133. Giraudo S.Q., Grace M.K., Billington C.J., Levine A.S. Differential effects of neuropeptide Y and the mu-agonist DAMGO on 'palatability' versus 'energy'. Brain Res. 834:1999;160-163
134. Giraudo S.Q., Grace M.K., Welch C.C., Billington C.J., Levine A.S. Naloxone's anorectic effect is dependent upon the relative palatability of food. Pharmacol. Biochem. Behav. 46:1993;917-921
135. Giraudo S.Q., Kotz C.M., Billington C.J., Levine A.S. Association between the amygdala and the nucleus of the solitary tract in mu opioid induced feeding in the rat. Brain Res. 802:1998;184-188
136. Glass M.J., Billington C.J., Levine A.S. Opioids and food intake: distributed functional neural pathways? Neuropeptides. 33:1999;360-368
137. Glass M.J., Billington C.J., Levine A.S. Role of lipid type on morphine-stimulated diet selection in rats. Am. J. Physiol. 277:1999;R1345-R1350
138. Glass M.J., Billington C.J., Levine A.S. Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. Am. J. Physiol. 279:2000;86-92
139. Glass M.J., Briggs J.E., Billington C.J., Kotz C.M., Levine A.S. Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression. Am. J. Physiol. 283:2002;R161-R167
140. Glass M.J., Grace M., Cleary J.P., Billington C.J., Levine A.S. Potency of naloxone's anorectic effect in rats is dependent on diet preference. Am. J. Physiol. 271:1996;R217-R221
141. Glass M.J., Grace M.K., Cleary J.P., Billington C.J., Levine A.S. Naloxone's effect on meal microstructure of sucrose and cornstarch diets. Am. J. Physiol. 281:2001;R1605-R16012
142. Glass M.J., Hahn B., Joseph A., Bodnar R.J. Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats. Brain Res. 657:1994;310-314
143. Glass M.J., O'Hare E., Cleary J.P., Billington C.J., Levine A.S. The effect of naloxone on food-motivated behavior in the obese Zucker rat. Psychopharmacology. 141:1999;378-384
144. Goldstein A., Fischli W., Lowney L.I., Hunkapiller M., Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. U.S.A. 74:1981;7219-7223
145. Gosnell B.A. Involvement of mu opioid receptors in the amygdala in the control of feeding. Neuropharmacology. 27:1988;319-326
146. Gosnell B.A., Grace M., Billington C.J., Levine A.S. Effects of streptozotocin-induced diabetes on feeding stimulated by centrally administered opioid agonists. Life Sci. 45:1989;31-40
147. Gosnell B.A., Grace M., Levine A.S. Effects of beta-chlornaltrexamine on food intake body weight and opioid-induced feeding. Life Sci. 40:1987;1459-1467
148. Gosnell B.A., Krahn D.D. The effects of continuous naltrexone infusions on diet preferences are modulated by adaptation to the diets. Physiol. Behav. 51:1992;239-244
149. Gosnell B.A., Krahn D.D. The effects of chronic morphine infusion on diet selection and body weight. Physiol. Behav. 54:1993;853-859
150. Gosnell B.A., Krahn D.D. Morphine-induced feeding: a comparison of the Lewis and Fischer 344 inbred rat strains. Pharmacol. Biochem. Behav. 44:1993;919-924
151. Gosnell B.A., Krahn D.D., Majchrzak M.J. The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharmacol. Biochem. Behav. 37:1990;207-212
152. Gosnell B.A., Levine A.S., Morley J.E. The effects of aging on opioid modulation of feeding in rats. Life Sci. 32:1983;2793-2799
153. Gosnell B.A., Levine A.S., Morley J.E. N-allylnormetazocine (SKF-10047): the induction of feeding by a putative sigma agonist. Pharmacol. Biochem. Behav. 19:1983;737-742
154. Gosnell B.A., Levine A.S., Morley J.E. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci. 38:1986;1081-1088
155. Gosnell B.A., Lipton J.M. Opioid peptide effects on feeding in rabbits. Peptides. 7:1986;745-747
156. Gosnell B.A., Majchrzak M.J. Centrally administered opioid peptides stimulate saccharin intake in nondeprived rats. Pharmacol. Biochem. Behav. 33:1989;805-810
157. Gosnell B.A., Majchrzak M.J. Effects of a selective mu opioid receptor agonist and naloxone on the intake of sodium chloride solutions. Psychopharmacology. 100:1990;66-71
158. Gosnell B.A., Majchrzak M.J., Krahn D.D. Effects of preferential delta and kappa opioid receptor agonists on the intake of hypotonic saline. Physiol. Behav. 47:1990;601-603
159. Gosnell B.A., Morley J.E., Levine A.S. Lesions of the globus pallidus and striatum attenuate ketocyclazocine-induced feeding. Physiol. Behav. 33:1984;349-355
160. Gosnell B.A., Morley J.E., Levine A.S. Opioid-induced feeding: localization of sensitive brain sites. Brain Res. 369:1986;177-184
161. Gosnell B.A., Morley J.E., Levine A.S., Kneip J., Frick M., Elde R.P. Opiate induced feeding is not dependent on the hippocampus. Physiol. Behav. 33:1984;27-30
162. Gosnell B.A., Patel C.K. Centrally administered mu- and delta-opioid agonists increase operant responding for saccharin. Pharmacol. Biochem. Behav. 45:1993;979-982
163. Gosnell B.A., Romsos D.R., Morley J.E., Levine A.S. Opiates and medial hypothalamic knife cuts cause hyperphagia through different mechanisms. Behav. Neurosci. 99:1985;1181-1191
164. Gosnell B.A., Waggoner D.W., Morley J.E., Levine A.S. The pineal gland and opiate-induced feeding. Physiol. Behav. 34:1985;1-6
165. Gracy K.N., Svingos A.L., Pickel V.M. Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the nucleus accumbens. J. Neurosci. 17:1997;4839-4848
166. Grandison L., Guidotti A. Stimulation of food intake by muscimol and beta-endorphin. Neuropharmacology. 16:1977;533-536
167. Grossman H.C., Hadjimarkou M.M., Silva R.M., Giraudo S.Q., Bodnar R.J. Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats. Brain Res. 991:2003;240-244
168. Gulati K., Ray A., Sharma K.K. Effects of acute and chronic morphine on food intake in rats: modulation by oxytocin and vasopressin. Pharmacol. Biochem. Behav. 40:1991;27-32
169. Gunion M.W., Peters R.H. Pituitary beta-endorphin, naloxone and feeding in several experimental obesities. Am. J. Physiol. 241:1981;R173-R184
170. Gysling K., Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res. 277:1983;119-127
171. Hadjimarkou MM, Abbadie C, Pan Y-X, Pasternak GW, Croll SD, Bodnar RJ. Time-dependent and site-specific upregulation of the MOR 1-C opioid splice variant following food restriction in rats. Soc. Neurosci. Abstr. 2003;23 [abstract viewer].
172. Hadjimarkou M.M., Khaimova E., Pan Y.-X., Rossi G.C., Pasternak G.W., Bodnar R.J. Feeding induced by food deprivation is differentially reduced by opioid receptor antisense oligodeoxynucleotide probes in rats. Brain Res. 987:2003;223-232
173. Hadjimarkou M.M., Silva R.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Feeding induced by food deprivation is differentially reduced by G-protein alpha-subunit antisense probes in rat. Brain Res. 955(1/2):2002;45-54
174. Hagan M.M., Moss D.E. An animal model of bulimia nervosa: opioid sensitivity to fasting episodes. Pharmacol. Biochem. Behav. 39:1991;421-422
175. Hagan M.M., Moss D.E. Effect of naloxone and antidepressants on hyperphagia produced by peptide YY. Pharmacol. Biochem. Behav. 45:1993;941-944
176. Hagan M.M., Rushing P.A., Benoit S.C., Woods S.C., Seeley R.J. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am. J. Physiol. 280:2001;R814-R821
177. Hahn E.F., Carroll-Buatti M., Pasternak G.W. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. J. Neurosci. 2:1982;572-576
178. Hamilton M.E., Bozarth M.A. Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area. Life Sci. 43:1988;941-946
179. Hanlon EC, Baldo BA, Sadeghian K, Kelley AE. Increases in food intake or food-seeking behavior induced by GABAergic, opioid, or dopaminergic stimulation of the nucleus accumbens: is it hunger? Psychopharmacology 2004:171, in press.
180. Hawkins M.F., Cubic B., Baumeister A.A., Bartin C. Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats. Brain Res. 584:1992;261-265
181. Hawkins M.F., Fuller R.D., Baumeister A.A., McCallum M.D. Effect in the rat of intranigral morphine and DAGO on eating and gnawing induced by stress. Pharmacol. Biochem. Behav. 49:1994;737-740
182. Haywood M.D., Low M.J. The effect of naloxone on operant behavior for food reinforcers in DBA/2 mice. Brain Res. Bull. 56:2001;537-543
183. Haywood M.D., Pintar J.E., Low M.J. Selective reward deficit in mice lacking beta-endorphin and enkephalin. J. Neurosci. 22:2002;8251-8258
184. Herkenham M., Moon Edley S., Stuart J. Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acetylcholinesterase and subcortical afferent terminations. Neuroscience. 11:1984;561-593
185. Higgs S., Cooper S.J. Midazolam-induced rapid changes in licking behaviour: evidence for involvement of endogenous opioid peptides. Psychopharmacology. 131:1997;278-286
186. Higgs S., Cooper S.J. Evidence for early opioid modulation of licking responses to sucrose and Intralipid: a microstructural analysis in the rat. Psychopharmacology. 139:1998;342-355
187. Hobbs D.J., Koch J.E., Bodnar R.J. Naltrexone, dopamine receptor agonists and antagonists and food intake in rats. 1. Food deprivation. Pharmacol. Biochem. Behav. 49:1994;197-204
188. Holtzman S.G. Behavioral effects of separate and combined administration of naloxone and D-amphetamine. J. Pharmacol. Exp. Ther. 189:1974;51-60
189. Holtzman S.G. Effects of narcotic antagonists on fluid intake in the rat. Life Sci. 16:1975;1465-1470
190. Holtzman S.G. Suppression of appetitive behavior in the rat by naloxone: lack of effect of prior morphine dependence. Life Sci. 24:1979;219-226
191. Horan P., Taylor J., Yamamura H.I., Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphamine (nor-BNI) in the mouse tail-flick test. J. Pharmacol. Exp. Ther. 260:1992;1237-1243
192. Hughes J., Smith T., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related penta-peptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-579
193. Imura H., Nakao K., Yanaihara N., Katsuura G., Nakamura M. Potent action of leumorphin on consummatory behaviors in rats: comparison with other opioid peptides. Neuroendocrinology. 44:1986;142-148
194. Islam A.K., Beczkowska I.W., Bodnar R.J. Interactions among aging, gender and gonadectomy effects upon naloxone hypophagia in rats. Physiol. Behav. 54:1993;981-992
195. Islam A.K., Bodnar R.J. Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats. Brain Res. 508:1990;293-296
196. Islam A.K., Dougherty T., Koch J.E., Bodnar R.J. Naltrexone, serotonin receptor subtype antagonists and carbohydrate intake in rats. Pharmacol. Biochem. Behav. 48:1994;193-201
197. Jackson A., Cooper S.J. Effects of K opiate agonists on palatable food consumption in non-deprived rats with and without food preloads. Brain Res. Bull. 15:1985;391-396
198. Jackson A., Cooper S.J. An observational analysis of the effect of the selective kappa opioid agonist, U50488H, on feeding and related behaviors in the rat. Psychopharmacology. 90:1986;217-221
199. Jackson H.C., Griffin I.J., Nutt D.J. Endogenous opioids may be involved in idazoxan-induced food intake. Neuropharmacology. 31:1992;771-776
200. Jackson H.C., Sewell R.D.E. Are delta opioid receptors involved in the regulation of food and water intake? Neuropharmacology. 24:1985;885-888
201. Jackson H.C., Sewell R.D.E. Hyperphagia induced by 2-deoxy-D-glucose in the presence of the delta-opioid antagonist, ICI174864. Neuropharmacology. 24:1985;815-817
202. Jalowiec J.E., Panksepp J., Zolovick A.J., Najam N., Herman B. Opioid modulation of ingestive behavior. Pharmacol. Biochem. Behav. 15:1981;477-484
203. Jenck F., Gratton A., Wise R.A. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Brain Res. 423:1986;39-44
204. Jenck F., Gratton A., Wise R.A. Opioid receptor subtypes associated with ventral tegmental area facilitation of lateral hypothalamic brain stimulation reward. Brain Res. 423:1987;34-38
205. Jewett D.C., Grace M.K., Jones R.M., Billington C.J., Portoghese P.S., Levine A.S. The kappa-opioid antagonist GNTI reduces U50488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain Res. 909:2001;75-80
206. Jones D.N.C., Holtzman S.G. Long-term kappa-opioid receptor blockade following nor-binaltorphamine. Eur. J. Pharmacol. 215:1992;345-348
207. Jones J.E., Corp E.S. Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status. Physiol. Behav. 78:2003;67-72
208. Jordan B.A., Cvejic S., Devi L.A. Opioids and their complicated complexes. Neuropsychopharmacology. 23:2000;S5-S18
209. Kalivas P.W., Churchill L., Klitenick M.A. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience. 57:1993;1047-1060
210. Kalivas P.W., Widerlov E., Stanley D., Breese G., Prange A.J. Enkephalin action on the meso-limbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Ther. 227:1983;229-237
211. Kangawa K., Minamino N., Chino N., Sakakibara S., Matsuo H. The complete amino acid sequence of alpha-neo-endorphin. Biochem. Biophys. Res. Commun. 99:1981;871-878
212. Kavaliers M., Hirst M. The influence of opiate agonists on day-night feeding rhythms in young and old mice. Brain Res. 326:1985;160-167
213. Kavaliers M., Teskey G.C., Hirst M. The effects of aging on day-night rhythms of kappa opiate-mediated feeding in the mouse. Psychopharmacology. 87:1985;286-291
214. Kelley A.E. Neural integrative activities of nucleus accumbens subregions in relation to learning and motivation. Psychobiology. 27:1999;198-213
215. Kelley A.E., Bakshi V.P., Haber S.N., Steininger T.L., Will M.J., Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 76(3):2002;365-377
216. Kelley A.E., Baksji V.P., Fleming S., Holahan M.R. A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens. Neuropsychopharmacology. 23:2000;455-467
217. Kelley A.E., Bless E.P., Swanson C.J. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J. Pharmacol. Exp. Ther. 278:1996;1499-1507
218. Kelley A.E., Swanson C.J. Feeding induced by blockade of AMPA and kainate receptors within the ventral striatum: a microinfusion mapping study. Behav. Brain Res. 89:1997;107-113
219. Kelley A.E., Will M.J., Steininger T.L., Zhang M., Haber S.N. Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkepahlin gene expression. Eur. J. Neurosci. 18:2003;2592-2598
220. Kennedy S.H., Goldbloom D.S. Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa. Drugs. 41:1991;367-377
221. Khaimova E, Kandov Y, Israel Y, Cataldo G, Hadjimarkou MM, Bodnar RJ. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area region in rats. Brain Res., submitted for publication.
222. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides. Cell Mol. Neurobiol. 15:1995;615-635
223. Kieffer B., Befort K., Gareiaux-Ruff C., Hirth C. The delta-opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89:1992;12048-12052
224. Kim E.M., Grace M.K., O'Hare E., Billington C.J., Levine A.S. Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC. Neuroreport. 13(4):2002;497-500
225. Kim E.M., Grace M.K., Welch C.C., Billington C.J., Levine A.S. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 276:1999;R1320-R1326
226. Kim E.M., Kotz C.M., Welch C.C., Grace M.K., Billington C.J., Levine A.S. Lactation increases mRNA levels of opioid peptides in the arcuate nucleus of the rat. Brain Res. 769:1997;303-308
227. Kim E.M., O'Hare E., Grace M.K., Welch C.C., Billington C.J., Levine A.S. ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean Zucker rats. Brain Res. 2000:2000;11-16
228. Kim E.M., Shi Q., Olszewski P.K., Grace M.K., O'Hare E., Billington C.J., et al. Identification of central sites involved in butorphanol-induced feeding in rats. Brain Res. 907:2001;125-129
229. Kim E.M., Welch C.C., Grace M.K., Billington C.J., Levine A.S. Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in the arcuate nucleus. Am. J. Physiol. 270:1996;R1019-R1024
230. Kimura S., Lewis R.V., Stern A.S., Rossier J., Stein S., Undenfriend S. Probable precursors of (leu) and (met)-enkephalin in adrenal medulla: peptides of 3-5 kilodaltons. Proc. Natl. Acad. Sci. U.S.A. 77:1980;1681-1685
231. King B.M., Castellanos F.X., Kastin A.J., Berzas M., Mauk D., Olson G.A., et al. Naloxone-induced suppression of food intake in normal and hypothalamic obese rats. Pharmacol. Biochem. Behav. 11:1979;729-732
232. Kirkham T.C. Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration. Physiol. Behav. 47:1990;419-426
233. Kirkham T.C., Blundell J.E. Dual action of naloxone on feeding revealed by behavioral analysis: separate effects on initiation and termination of eating. Appetite. 5:1984;45-52
234. Kirkham T.C., Blundell J.E. Effects of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with D-amphetamine and D-fenfluramine. Pharmacol. Biochem. Behav. 25:1986;123-128
235. Kirkham T.C., Cooper S.J. Attenuation of sham feeding by naltrexone is stereospecific: evidence for opioid mediation of orosensory reward. Physiol. Behav. 43:1988;845-847
236. Kirkham T.C., Cooper S.J. Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44:1988;491-494
237. Klitenick M.A., Wirtshafter D. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area. J. Pharmacol. Exp. Ther. 273:1995;327-336
238. Koch J.E., Beczkowska I.W., Bodnar R.J. Naltrexone, serotonin receptor subtype antagonists and glucoprivic intake. II. Insulin. Pharmacol. Biochem. Behav. 42:1992;671-680
239. Koch J.E., Bodnar R.J. Involvement of mu-1 and mu-2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol. Behav. 53:1993;603-605
240. Koch J.E., Bodnar R.J. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Brain Res. 657:1994;191-201
241. Koch J.E., Glass M.J., Cooper M.L., Bodnar R.J. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience. 66:1995;951-957
242. Koch J.E., Pasternak G.W., Arjune D., Bodnar R.J. Naloxone benzoylhydrazone, a kappa-3 opioid agonist, stimulates food intake in rats. Brain Res. 581:1992;311-314
243. Kohno M., Fukushima N., Yoshida A., Ueda H. Gi1 and Go differentially determine kinetic efficacies of agonists for kappa-opioid receptor. FEBS Lett. 473:2000;101-105
244. Kotz C.M., Billington C.J., Levine A.S. Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am. J. Physiol. 272:1997;R1028-R1032
245. Kotz C.M., Glass M.J., Levine A.S., Billington C.J. Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. Am. J. Physiol. 278:2000;R499-R503
246. Kotz C.M., Grace M.K., Billington C.J., Levine A.S. The effect of nor-binaltorphamine beta-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res. 631:1993;325-328
247. Kotz C.M., Grace M.K., Briggs J.E., Billington C.J., Levine A.S. Naltrexone induces arcuate nucleus neuropeptide Y gene expression in the rat. Am. J. Physiol. 271:1996;R289-R294
248. Kotz C.M., Grace M.K., Briggs J., Levine A.S., Billington C.J. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. J. Clin. Invest. 96:1995;163-170
249. Kotz C.M., Levine A.S., Billington C.J. Effect of naltrexone on feeding, neuropeptide Y and uncoupling protein gene expression during lactation. Neuroendocrinology. 65:1997;259-264
250. Kumar R., Mitchell E., Stolerman I.P. Disturbed patterns of behaviour in morphine tolerant and abstinent rats. Br. J. Pharmacol. 42:1971;473-484
251. Kuta C.C., Bryant H.U., Zabik J.E., Yim G.K.W. Stress, endogenous opioids and salt intake. Appetite. 5:1984;53-60
252. Lamonte N, Ackerman TF, Bodnar RJ. Opioid subtype antagonist modulation of mu opioid-induced feeding: ventral tegmental area and nucleus accumbens interactions in rats. Soc. Neurosci. Abstr. 2002;28 [abstract viewer].
253. Lamonte N., Echo J.A., Ackerman T.F., Christian G., Bodnar R.J. Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats. Brain Res. 929:2002;96-100
254. Langhans W., Scharrer E. Evidence for a vagally mediated satiety signal derived from hepatic fatty acid oxidation. J. Autonom. Nerv. Syst. 18:1987;13-18
255. Leibowitz S.F., Hor L. Endorphinergic and alpha-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides. 3:1982;421-428
256. Leone P., Pocock D., Wise R.A. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol. Biochem. Behav. 39:1991;469-472
257. Leshem M. Morphine induces delayed anorexia in rats. Psychopharmacology. 94:1988;254-258
258. Leventhal L., Bodnar R.J. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats. Brain Res. 741:1996;300-308
259. Leventhal L., Cole J.L., Rossi G.C., Pan Y.X., Pasternak G.W., Bodnar R.J. Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats. Brain Res. 719:1996;78-84
260. Leventhal L., Kirkham T.C., Cole J.L., Bodnar R.J. Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-feeding rats. Brain Res. 685:1995;205-210
261. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., Bodnar R.J. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur. J. Pharmacol. 349:1998;R1-R3
262. Leventhal L., Silva R.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats. J. Pharmacol. Exp. Ther. 287:1998;538-544
263. Leventhal L., Stevens L.B., Rossi G.C., Pasternak G.W., Bodnar R.J. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO. J. Pharmacol. Exp. Ther. 282:1997;1402-1407
264. Levine A.S., Grace M., Billington C.J. The effect of centrally administered naloxone on deprivation and drug-induced feeding. Pharmacol. Biochem. Behav. 36:1990;409-412
265. Levine A.S., Grace M., Billington C.J. B-funaltrexamine (B-FNA) decreases deprivation and opioid-induced feeding. Brain Res. 562:1991;281-284
266. Levine A.S., Grace M., Billington C.J., Gosnell B.A., Krahn D.D., Brown D.M., et al. Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats. Pharmacol. Biochem. Behav. 29:1988;495-500
267. Levine A.S., Grace M., Billington C.J., Portoghese P.S. Nor-binaltorphamine decreases deprivation and opioid-induced feeding. Brain Res. 534:1990;60-64
268. Levine A.S., Grace M., Billington C.J., Zimmerman D.M. Central administration of the opioid antagonist LY255582 decreases short- and long-term food intake in rats. Brain Res. 566:1991;193-197
269. Levine A.S., Grace M.K., Cleary J.P., Billington C.J. Naltrexone infusion inhibits the development of preference for a high-sucrose diet. Am. J. Physiol. 283(5):2002;R1149-R1154
270. Levine A.S., Grace M., Portoghese P.S., Billington C.J. The effect of selective opioid antagonists on butorphanol-induced feeding. Brain Res. 637:1994;242-248
271. Levine A.S., Morley J.E. Peptidergic control of insulin-induced feeding. Peptides. 2:1981;261-264
272. Levine A.S., Morley J.E. Adrenal modulation of opiate induced feeding. Pharmacol. Biochem. Behav. 19:1983;403-406
273. Levine A.S., Morley J.E. Butorphenol tartrate induces feeding in rats. Life Sci. 32:1983;781-785
274. Levine A.S., Morley J.E., Brown D.M., Handwerger B.S. Extreme sensitivity of diabetic mice to naloxone-induced suppression of food intake. Physiol. Behav. 28:1982;987-989
275. Levine A.S., Morley J.E., Gosnell B.A., Billington C.J., Bartness T.J. Opioids and consummatory behavior. Brain Res. Bull. 14:1985;663-672
276. Levine A.S., Morley J.E., Kneip J., Grace M., Brown D.M. Environment modulates naloxone's suppressive effect on feeding in diabetic and non-diabetic rats. Physiol. Behav. 34:1985;391-393
277. Levine A.S., Murray S.S., Kneip J., Grace M., Morley J.E. Flavor enhances the antidipsogenic effect of naloxone. Physiol. Behav. 28:1982;23-25
278. Levine A.S., Weldon D.T., Grace M., Cleary J.P., Billington C.J. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am. J. Physiol. 268:1995;R248-R252
279. Lewis M.E., Khachaturian H., Watson S.J. Combined autoradiographic- immunocytochemical analysis of opioid receptors and opioid peptide neuronal systems in brain. Peptides. 6:1985;37-47
280. Li C.S., Davis B.J., Smith D.V. Opioid modulation of taste responses in the nucleus of the solitary tract. Brain Res. 965:2003;21-34
281. Locatelli V., Petraglia F., Tirloni N., Muller E.E. Beta-endorphin concentrations in the hypothalamus, pituitary and plasma of streptozotocin- diabetic rats with and without insulin substitution therapy. Life Sci. 38:1986;379-386
282. Locke K.W., Brown D.R., Holtzman S.G. Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey. Pharmacol. Biochem. Behav. 17:1982;1275-1279
283. Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H. Endogenous opioid peptides: multiple agonists and receptors. Nature. 267:1977;495-499
284. Low M.J., Haywood M.D., Appleyard S.M., Rubinstein M. State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin. Ann. NY Acad. Sci. 994:2003;192-201
285. Lowy M.T., Maickel R.P., Yim G.K.W. Naloxone reduction of stress-related feeding. Life Sci. 26:1980;2113-2118
286. Lowy M.T., Yim G.K.W. Stimulation of food intake following opiate agonists in rats but not hamsters. Psychopharmacology. 81:1983;28-32
287. Lynch W.C. Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol. Biochem. Behav. 24:1986;833-836
288. Lynch W.C., Burns G. Opioid effects on intake of sweet solutions depend both on prior drug experience and on prior ingestive experience. Appetite. 15:1990;23-32
289. Lynch W.C., Libby L. Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats. Life Sci. 33:1983;1909-1914
290. MacDonald A.F., Billington C.J., Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am. J. Physiol. 285:2003;R999-R1004
291. Maickel R.P., Braude M.C., Zabik J.E. The effects of various narcotic agonists and antagonists on deprivation-induced fluid consumption. Neuropharmacology. 16:1977;863-866
292. Mains R.E., Eipper B.A., Ling N. Common precursor to corticotropins and endorphin. Proc. Natl. Acad. Sci. U.S.A. 1974:1977;3014-3018
293. Majeed N.H., Lason W., Przewlocka B., Przewlocki R. Brain and peripheral opioid peptides after changes in ingestive behavior. Neuroendocrinology. 42:1986;267-272
294. Majeed N.H., Przewlocka B., Wedzony K., Przewlocki R. Stimulation of food intake following opioid microinjection into the nucleus accumbens septi in rats. Peptides. 7:1986;711-716
295. Malcolm R., O'Neil P.M., Sexauer J.D., Riddle F.E., Currey H.S., Counts C. A controlled trial of naltrexone in obese humans. Int. J. Obes. 9:1985;347-353
296. Maldonado-Irizarry C.S., Swanson C.J., Kelley A.E. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J. Neurosci. 15:1995;6779-6788
297. Mandenoff A., Fumeron F., Apfelbaum M., Margules D.L. Edogenous opiates and energy balance. Science. 215:1982;1536-1537
298. Mann P.E., Arjune D., Romero M.T., Pasternak G.W., Hahn E.F., Bodnar R.J. Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine. Psychopharmacology. 94:1988;330-341
299. Mann P.E., Pasternak G.W., Hahn E.F., Curreri G., Lubin E., Bodnar R.J. Comparison of chronic naloxone and naloxonazine effects upon food intake and body weight maintenance in rats. Neuropharmacology. 27:1988;349-355
300. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8:1995;283-305
301. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.T. Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464
302. Margules D.L., Moisset B., Lewis M.J., Shibuya H., Pert C.B. Beta-endorphin is associated with overeating in genetically-obese mice (ob/ob) and rats (fa/fa). Science. 202:1978;988-991
303. Marks-Kaufman R. Increased fat consumption induced by morphine administration in rats. Pharmacol. Biochem. Behav. 16:1982;949-955
304. Marks-Kaufman R., Balmagiya T., Gross E. Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol. Biochem. Behav. 20:1984;911-916
305. Marks-Kaufman R., Kanarek R. Morphine selectively influences macronutrient intake in the rat. Pharmacol. Biochem. Behav. 12:1980;427-430
306. Marks-Kaufman R., Kanarek R. Modifications of nutrient selection by naloxone in rats. Psychopharmacology. 74:1981;321-324
307. Marks-Kaufman R., Kanarek R. Diet selection following a chronic morphine and naloxone regimen. Pharmacol. Biochem. Behav. 35:1990;665-669
308. Marks-Kaufman R., Lipeles B.J. Patterns of nutrient selection in rats who are self-administering morphine. Nutr. Behav. 1:1982;33-46
309. Marks-Kaufman R., Plager A., Kanarek R. Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats. Psychopharmacology. 85:1985;414-418
310. Martin G., Zhiguo N., Siggins G.R. Mu-opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17(1):1997;11-22
311. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532
312. Martin W.R., Wikler A., Eades C.G., Pescor F.T. Tolerance to and physical dependence on morphine in rats. Psychopharmacology. 4:1963;247-260
313. McLaughlin C.L., Baile C.A. Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats. Pharmacol. Biochem. Behav. 19:1983;235-240
314. McLaughlin C.L., Baile C.A. Feeding behavior responses of Zucker rats to naloxone. Physiol. Behav. 32:1984;755-761
315. McLaughlin C.L., Baile C.A. Increased sensitivity of Zucker obese rats to naloxone is present at weaning. Physiol. Behav. 32:1984;929-933
316. McLaughlin C.L., Baile C.A., Della-Fera M.A. Circadian rhythm of feeding induced changes in hypothalamic met-enkephalin concentrations. Physiol. Behav. 41:1987;465-469
317. McLean S., Hoebel B.G. Opiate and norepinephrine-induced feeding from the paraventricular nucleus of the hypothalamus are dissociable. Life Sci. 31:1982;2379-2382
318. McLean S., Hoebel B.G. Feeding induced by opiates injected into the paraventricular hypothalamus. Peptides. 4:1983;287-292
319. Mehiel R. The effects of naloxone on flavor-calorie preference learning indicate involvement of opioid reward systems. Psychol. Rec. 46:1996;435-450
320. Meredith G.E., Pennartz C.M., Groenewegen H.J. The cellular framework for chemical signalling in the nucleus accumbens. Prog. Brain Res. 99:1993;3-24
321. Meunier J.C., Mollereau C., Toll L., Suadeau C., Moisand C., Alvinerie P., et al. Isolation and structure of the endogenous agonist of the opioid receptor like ORL1 receptor. Nature. 377:1995;532-535
322. Millan M.J., Morris B.J. Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behavior, body weight and core temperature in the rat. Brain Res. 450:1988;247-258
323. Misawa H., Ueda H., Katada T., Ui M., Satoh M. A subtype of opioid kappa-receptor is coupled to inhibition of Gi1-mediated phospholipase c activity in the guinea pig cerebellum. FEBS Lett. 361:1995;106-110
324. Mitchell J.E., Laine D.E., Morley J.E., Levine A.S. Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome. Biol. Psychiat. 21:1986;1399-1406
325. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., et al. ORL-1, a novel member of the opioid family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38
326. Morley J.E., Levine A.S. Stress-induced eating is mediated through endogenous opiates. Science. 209:1980;1259-1261
327. Morley J.E., Levine A.S. Dynorphin (1-13) induces spontaneous feeding in rats. Life Sci. 29:1981;1901-1903
328. Morley J.E., Levine A.S. Dynorphin (1-13), dopamine and feeding in rats. Pharmacol. Biochem. Behav. 16:1982;701-705
329. Morley J.E., Levine A.S. Dynorphin (1-13) induces spontaneous feeding in rats. Life Sci. 29:1983;1901-1903
330. Morley J.E., Levine A.S. Involvement of dynorphin and the kappa opioid receptor in feeding. Peptides. 4:1983;797-800
331. Morley J.E., Levine A.S., Gosnell B.A., Kneip J., Grace M. The kappa opioid receptor ingestive behaviors and the obese mouse (ob/ob). Physiol. Behav. 31:1983;603-606
332. Morley J.E., Levine A.S., Grace M., Kneip J. An investigation of the role of kappa opiate receptors in the initiation of feeding. Life Sci. 31:1982;2617-2626
333. Morley J.E., Levine A.S., Grace M., Kneip J., Gosnell B.A. The effect of ovariectomy, estradiol and progesterone on opioid modulation of feeding. Physiol. Behav. 33:1984;237-241
334. Morley J.E., Levine A.S., Kneip J., Grace M., Billington C.J. The effect of peripherally administered satiety substances on feeding induced by butorphanol tartrate. Pharmacol. Biochem. Behav. 19:1983;577-582
335. Morley J.E., Levine A.S., Kneip J., Grace M., Zeugner H., Shearman G.T. The K opioid receptor and food intake. Eur. J. Pharmacol. 112:1985;17-25
336. Morley J.E., Levine A.S., Plotka E.D., Seal U.S. The effect of naloxone on feeding and spontaneous locomotion in the wolf. Physiol. Behav. 30:1983;331-334
337. Morley J.E., Levine A.S., Yim G.K.W., Lowy M.T. Opioid modulation of appetite. Neurosci. Biobehav. Rev. 7:1983;281-305
338. Morley J.E., Parker S., Levine A.S. Effect of butorphanol tartrate on food and water consumption in humans. Am. J. Clin. Nutr. 42:1985;1175-1178
339. Moufid-Bellancourt S., Velley L. Effects of morphine injection into the parabrachial area on saccharin preference: modulation by lateral hypothalamic neurons. Pharmacol. Biochem. Behav. 48:1994;127-133
340. Mucha R.F., Iversen S.D. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res. 397:1986;214-224
341. Myers K.J., Dean N.M. Sensible use of antisense: how to use oligonucleotides as research tools. Trends Pharmacol. Sci. 21(1):2000;19-23
342. Nader K., van der Kooy D. The motivation produced by morphine and food is isomorphic: approaches to specific motivational stimuli are learned. Psychobiology. 22:1994;68-76
343. Nencini P. The role of opiate mechanisms in the development of tolerance to the anorectic effects of amphetamine. Pharmacol. Biochem. Behav. 30:1988;755-764
344. Nencini P., Fraioli S. Environment-specific reinstatement of amphetamine-mediated hyperdispsia by morphine and (-)-norpseudoephedrine. Pharmacol. Biochem. Behav. 47:1994;339-343
345. Nencini P., Graziani M. Opioidergic modulation of preparatory and consummatory components of feeding and drinking. Pharmacol. Biochem. Behav. 37:1990;531-537
346. Nencini P., Johanson C.E., Schuster C.R. Sensitization to kappa opioid mechanisms associated with tolerance to the anorectic effect of cathione. J. Pharmacol. Exp. Ther. 245:1988;147-154
347. Nencini P., Stewart J. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50488H, microinjected into the ventral tegmental area in rats. Brain Res. 527:1990;254-258
348. Nencini P., Valeri P. The role of opioid mechanisms in the anorectic effects of stimulants: U50488H enhances amphetamine inhibition of free feeding in rats. Pharmacol. Biochem. Behav. 48:1994;63-68
349. Nencini P., Valeri P., Pimpinella G. The alpha-1 blocker dapiprazole inhibits diuresis but not drinking and feeding induced by U50488H. Brain Res. Bull. 29:1992;401-405
350. Nicklous D.M., Simansky K.J. Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake. Am. J. Physiol. 285:2003;R1046-R1054
351. Nizielski S.E., Morley J.E., Gosnell B.A., Seal U.S., Levine A.S. Opioid modulation of ingestive behaviors in woodchucks and raccoons. Physiol. Behav. 34:1985;171-176
352. Nock B., Rajpara A., O'Connor L.H., Cicero T.J. Autoradiography of [3-H]-U69593 binding sites in rat brain: evidence for K opioid receptor subtypes. Eur. J. Pharmacol. 154:1988;27-34
353. Noel M.B., Wise R.A. Ventral tegmental injections of morphine but not U50488H enhance feeding in food-deprived rats. Brain Res. 632:1993;68-73
354. Noel M.B., Wise R.A. Ventral tegmental injections of a selective mu or delta opioid enhance feeding in food-deprived rats. Brain Res. 673:1995;304-312
355. Odum A.L., Haworth S.C., Schaal D.W. Food-deprivation level alters the effect of morphine on pigeons' key pecking. J. Exp. Anal. Behav. 69:1998;295-310
356. O'Hare E., Cleary J., Bartz P.J., Weldon D.T., Billington C.J., Levine A.S. Naloxone administration following operant training of sucrose/water discrimination in the rat. Psychopharmacology. 129:1997;289-294
357. O'Hare E., Levine A.S., Semotuk M.T., Tierney K.J., Shephard R.A., Grace M.K., et al. Utilization of a novel model of food reinforced behavior involving neuropeptide Y, insulin, 2-deoxy-D-glucose and naloxone. Behav. Pharmacol. 7:1996;742-753
358. Olson G.A., DeLatte S.W., Kastin A.J., McLean J.H., Phillpott D.F., Olson R.D. Naloxone and fluid consumption in rats: dose-response relationship for 15 days. Pharmacol. Biochem. Behav. 23:1985;1065-1068
359. Olszewski P.K., Billington C.J., Levine A.S. Fos expression in feeding-related brain areas following intracerebroventricular administration of orphanin FQ in rats. Brain Res. 855:2000;171-175
360. Olszewski P.K., Grace M.K., Billington C.J., Levine A.S. The effect of [Phe(1)psi(CH(2)-NH)Gly(2)]-nociceptin(1-13)NH(2) on feeding and c-Fos immunoreactivity in selected brain sites. Brain Res. 876(1/2):2000;95-102
361. Olszewski P.K., Grace M.K., Sanders J.B., Billington C.J., Levine A.S. Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference. Pharmacol. Biochem. Behav. 73:2002;529-535
362. Olszewski P.K., Shaw T.J., Grace M.K., Billington C.J., Levine A.S. Nocistatin inhibits food intake in rats. Brain Res. 872:2000;181-187
363. Olszewski P.K., Wirth M.M., Grace M.K., Levine A.S., Giraudo S.Q. Evidence of interactions between melanocortin and opioid systems in regulation of feeding. Neuroreport. 12:2001;1727-1730
364. Ookuma K., Barton C., York D.A., Bray G.A. Effect of enterostatin and kappa-opioids on macronutrient selection and consumption. Peptides. 18:1997;785-791
365. Ookuma K., Barton C., York D.A., Bray G.A. Differential response to kappa-opioidergic agents in dietary fat selection between Osborne-Mendel and S5B/P1 rats. Peptides. 19:1998;141-147
366. Oomura Y., Nishina H., Aou S., Lenard L. Opiate mechanism in reward-related responses during operant feeding behavior of the monkey. Brain Res. 365:1986;335-339
367. Ostrowski N.L., Rowland N., Foley T.L., Nelson J.L., Reid L.D. Morphine antagonists and consummatory behaviors. Pharmacol. Biochem. Behav. 14:1981;549-559
368. Ottoviani R., Riley A.L. Effect of chronic morphine administration on the self-selection of macronutrients in the rat. Nutr. Behav. 2:1984;27-36
369. Pan Y.X., Xu J., Bolan E., Abbadie C., Chang A., Zuckerman A., et al. Identification and characterization of three new alternatively spliced MOR-1 opioid receptor isoforms. Mol. Pharmacol. 56:1999;396-403
370. Pan Y.X., Xu J., Bolan E., Chang A., Mahurter L., Rossi G.C., et al. Isolation and expression of a novel alternatively spliced mu receptor isoform, MOR-1F. FEBS Lett. 466:2000;337-340
371. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U.S.A. 98:2001;14084-14089
372. Paolone G., Burdino R., Badiani A. Dissociation in the modulatory effects of environmental novelty on the locomotor, analgesic and eating responses top acute and repeated morphine in the rat. Psychopharmacology. 166:2003;146-155
373. Papadouka V., Carr K.D. The role of multiple opioid receptors in the maintenance of stimulation-induced feeding. Brain Res. 639:1994;42-48
374. Parker L.A., Maier S., Rennie M., Crebolder J. Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test. Behav. Neurosci. 106:1992;999-1010
375. Paronis C.A., Waddell A.B., Holtzman S.G. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphamine. Pharmacol. Biochem. Behav. 46:1993;813-817
376. Pasternak G.W. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci. 22:2001;67-70
377. Pasternak G.W., Pan Y.X. Antisense mapping: assessing functional significance of genes and splice variants. Meth. Enzymol. 314:2000;51-60
378. Pasternak G.W., Standifer K.M. Mapping of opioid receptors using antisense oligodeoxynucleotides: Correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16:1995;344-350
379. Pasternak G.W., Wood P.L. Multiple mu opiate receptors. Life Sci. 38:1986;1889-1896
380. Pecina S., Berridge K.C. Central enhancement of taste pleasure by intraventricular morphine. Neurobiology. 3:1995;269-280
381. Pecina S., Berridge K. Opioid site in nucleus accumbens shell mediates eating and hedonic 'liking' for food: map based on microinjection Fos plumes. Brain Res. 863:2000;71-86
382. Pert C.B., Snyder S.H. Opiate receptor: demonstration in nervous tissue. Science. 179:1973;1011-1014
383. Pfeiffer D.G., Nikolarakis K.E., Pfeiffer A. Chronic blockade of opiate receptors: influence on reproduction and body weights in female rats. Neuropeptides. 5:1984;279-282
384. Plata-Salaman C.R., Wilson C.D., Sonti G., Borkoski J.P., ffrench-Mullen J.M.H. Antisense oligodeoxynucleotides to G-protein alpha-subunit subclasses identify a transductional requirement for the modulation of normal feeding dependent on Goa alpha subunit. Mol. Brain Res. 33:1995;72-78
385. Plotka E.D., Morley J.E., Levine A.S., Seal U.S. Effects of opiate antagonists on feeding and spontaneous locomotion in deer. Physiol. Behav. 35:1985;965-969
386. Polidori C., Calo G., Ciccocioppo R., Guerini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology. 148:2000;430-437
387. Polidori C., deCaro G., Massi M. The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides. 21:2000;1051-1062
388. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport. 8:1996;369-371
389. Pomonis J.D., Jewett D.C., Kotz C.M., Briggs J.E., Billington C.J., Levine A.S. Sucrose consumption increases naloxone-induced c-fos immunoreactivity in limbic forebrain. Am. J. Physiol. 278:2000;R712-R719
390. Pomonis J.D., Levine A.S., Billington C.J. Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression. J. Neurosci. 17:1997;5175-5182
391. Portoghese P.S., Larson D.L., Sayre L.M., Fries D.S., Takemori A.E. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J. Med. Chem. 23:1980;233-234
392. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphamine and nor-binaltorphamine, potent and selective K-opioid receptor antagonists. Life Sci. 40:1987;1287-1292
393. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186
394. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole 5′-isothiocyanate: a non-equilibrium, highly selective delta opioid receptor antagonist. J. Med. Chem. 33:1990;1547-1548
395. Przewlocki R., Lason W. The opioid peptide dynorphin circadian rhythms and starvation. Science. 219:1982;71-73
396. Quinn J.G., O'Hare E., Levine A.S., Kim E.M. Evidence for a mu-opioid-opioid connection between the paraventricular nucleus and ventral tegmental area in the rat. Brain Res. 991:2003;206-211
397. Ragnauth A., Moroz M., Bodnar R.J. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats. Brain Res. 876:2000;76-87
398. Ragnauth A., Ruegg H., Bodnar R.J. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 767:1997;8-16
399. Ragnauth A., Schuller A., Morgan M., Chan J., Ogawa S., Pintar J., et al. Female preproenkephalin-knockout mice display altered emotional responses. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1958-1963
400. Ragnauth A., Znamensky V., Moroz M., Bodnar R.J. Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens. Brain Res. 877:2000;65-72
401. Ramirez I. Intragastric carbohydrate exerts both intake-stimulating and intake-suppressing effects. Behav. Neurosci. 111:1997;612-622
402. Recant L., Voyles N.R., Luciano M., Pert C.B. Naltrexone reduced weight gain, alters beta-endorphin and reduces insulin output from pancreatic islets of genetically obese mice. Peptides. 1:1980;309-313
403. Reid L.D. Endogenous opioid peptides and regulation of drinking and feeding. Am. J. Clin. Nutr. 42:1985;1099-1132
404. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794
405. Reisine T., Bell G.I. Molecular biology of opioid receptors. Trends Neurosci. 16:1993;506-510
406. Ritter S., Taylor J.S. Capsaicin abolishes lipoprivic but not glucoprivic feeding in rats. Am. J. Physiol. 256:1989;R1232-R1239
407. Rizzi A., Salis M.B., Ciccocioppo R., Marzola G., Bigoni R., Guerrini R., et al. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch. Pharmacol. 365(6):2002;450-456
408. Roane D.S., Iadarola M.J., Porter J.R. Decreased [3H]-naloxone binding and elevated dynorphin-A(1-8) content in the Zucker rat brain. Physiol. Behav. 43:1988;371-374
409. Robert J.J., Orosco M., Rouch C., Jacquot C., Cohen Y. Effects of opiate agonists and an antagonist on food intake and brain neurotransmitters in norphophagic and obese 'cafeteria' rats. Pharmacol. Biochem. Behav. 34:1989;577-583
410. Roberts J.L., Seeburg P.H., Shine J., Herbert E., Baxter J.D., Goodman H.M. Corticotropin and β-endorphin: construction of analysis of recombinant DNA complementary to mRNA for the common precursor. Proc. Natl. Acad. Sci. U.S.A. 76:1979;2153-2157
411. Rockwood G.A., Reid L.D. Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas. Physiol. Behav. 29:1982;1175-1178
412. Rodi D., Polidori C., Bregola G., Zucchini S., Simonato M., Massi M. Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats. Brain Res. 957(2):2002;354-361
413. Roerig S.C. Opioid regulation of second messenger systems. Analgesia. 3:1998;231-250
414. Romsos D.R., Gosnell B.A., Morley J.E., Levine A.S. Effects of kappa opioid agonists, cholecystokinin and bomsesin on intake of diets varying in carbohydrate-to-fat ratio in rats. J. Nutr. 117:1987;976-985
415. Rossi G.C., Leventhal L., Pan Y.-X., Cole J., Su W., Bodnar R.J., et al. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281:1997;109-114
416. Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W. Antisense mapping the MOR-1 receptor: evidence for alternative splicing and a novel morphine-6beta-glucuronide receptor. FEBS Lett. 369:1995;192-196
417. Rossi GC, Pasternak GW. Establishing the molecular biology of opioid behavior through antisense approaches. In: Weiss B, editor. Antisense oligodeoxynucleotides and antisense RNA. Boca Raton, FL: CRC Press. p. 115-30.
418. Rossi G.C., Standifer K.M., Pasternak G.W. Differential blockade of morphine and morphine-6B-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci. Lett. 198:1995;99-102
419. Rowland N. Comparison of the suppression by naloxone of water intake induced in rats by hyperosmolarity, hypovolemia and angiotensin. Pharmacol. Biochem. Behav. 16:1982;87-91
420. Rowland N., Bartness T.J. Naloxone suppresses insulin-induced food intake in novel and familiar environments, but does not affect hypoglycemia. Pharmacol. Biochem. Behav. 16:1982;1001-1003
421. Rudski J.M., Billington C.J., Leveine A.S. A sucrose-based maintenance diet increases sensitivity to appetite suppressant effects of naloxone. Pharmacol. Biochem. Behav. 58:1997;679-682
422. Rudski J.M., Billington C.J., Levine A.S. Butorphanol increases food-reinforced operant responding in satiated rats. Pharmacol. Biochem. Behav. 49:1994;843-847
423. Rudski J.M., Billington C.J., Levine A.S. Naloxone's effects on operant responding depend upon level of deprivation. Pharmacol. Biochem. Behav. 49:1994;377-383
424. Rudski J.M., Grace M., Kuskowski M.A., Billington C.J., Levine A.S. Behavioral effects of naloxone on neuropeptide Y-induced feeding. Pharmacol. Biochem. Behav. 54:1996;771-777
425. Rudski J.M., Schaal D.W., Thompson T., Cleary J., Billington C.J., Levine A.S. Effects of methadone on free feeding in satiated rats. Pharmacol. Biochem. Behav. 43:1992;1033-1037
426. Rudski J.M., Schaal D.W., Thompson T., Cleary J., Billington C.J., Levine A.S. Methadone and feeding: sources of differences between home cage and operant chamber assessment procedures. Pharmacol. Biochem. Behav. 49:1994;143-146
427. Rudski J.M., Thomas D., Billington C.J., Levine A.S. Buprenorphine increases intake of freely available and operant-contingent food in satiated rats. Pharmacol. Biochem. Behav. 50:1995;271-276
428. Ruegg H., Hahn B., Koch J.E., Bodnar R.J. Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats. Brain Res. 635:1994;203-210
429. Ruegg H., Yu W.-Z., Bodnar R.J. Opioid receptor subtype agonist-induced enhancements of sucrose intake are dependent upon sucrose concentration. Physiol. Behav. 62:1997;121-128
430. Sanger D.J. Endorphinergic mechanisms in the control of food and water intake. Appetite. 2:1981;193-208
431. Sanger D.J., McCarthy P.S. Differential effects of morphine on food and water intake in food deprived and freely feeding rats. Psychopharmacology. 72:1980;103-106
432. Sanger D.J., McCarthy P.S. Increased food and water intake produced by rats by opiate receptor agonists. Psychopharmacology. 74:1981;217-220
433. Schaefer L.A., Koch J.E., Bodnar R.J. Naltrexone, dopamine receptor agonists and antagonists and food intake in rats. 2. 2-Deoxy-D-glucose. Pharmacol. Biochem. Behav. 49:1994;205-211
434. Schulz R., Wilhelm A., Dirlich G. Intracerebral microinjection of different antibodies against the endogenous opioids suggests alpha-neoendorphin participation in control of feeding behavior. Naunyn Schmiedebergs Arch. Pharmacol. 326:1984;222-226
435. Sclafani A, Aravich PF, Xenakis S. Dopaminergic and endorphinergic mediation of a sweet reward. In: Hoebel BG, Novin D, editors. The neural basis of feeding and reward. Brunswick, ME: Haer Institute. p. 507-15.
436. Segall M.A., Margules D.L. Central mediation of naloxone-induced anorexia in the ventral tegmental area. Behav. Neurosci. 103:1989;857-864
437. Self D.W., Stein L. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:1992;87-94
438. Shabir S., Kirkham T.C. Diet-induced enhancement of naloxone sensitivity is independent of changes in body weight. Pharmacol. Biochem. Behav. 62:1999;601-605
439. Shaw W.N., Mitch C.H., Leander J.D., Zimmerman D.M. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat. J. Pharmacol. Exp. Ther. 253:1990;85-89
440. Shide D.J., Blass E.M. Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats. Physiol. Behav. 50:1991;961-966
441. Shimomura Y., Oku J., Glick Z., Bray G.A. Opiate receptors, food intake and obesity. Physiol. Behav. 28:1982;441-445
442. Shor-Posner G., Azar A.P., Filart R., Tempel D., Leibowitz S.F. Morphine-stimulated feeding: analysis of macronutrient selection and paraventricular nucleus lesions. Pharmacol. Biochem. Behav. 24:1986;931-939
443. Sills T.L., Vaccarino F.J. Individual differences in the feeding and locomotor stimulatory effects of acute and repeated morphine treatments. Pharmacol. Biochem. Behav. 60:1998;293-303
444. Silva R.M., Grossman H.C., Hadjimarkou M.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Dynorphin A1-17-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J. Pharmacol. Exp. Ther. 301:2002;513-518
445. Silva R.M., Grossman H.C., Rossi G.C., Pasternak G.W., Bodnar R.J. Pharmacological characterization of beta-endorphin- and dynorphin A-induced feeding using g-protein alpha subunit antisense probes in rats. Peptides. 23:2002;1101-1106
446. Silva R.M., Hadjimarkou M.M., Rossi G.C., Pasternak G.W., Bodnar R.J. Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J. Pharmacol. Exp. Ther. 297:2001;590-596
447. Silva R.M., Rossi G.C., Mathis J.P., Standifer K.M., Pasternak G.W., Bodnar R.J. Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats. Brain Res. 876:2000;62-75
448. Simon E.J., Hiller J.M., Edelman I. Stereospecific binding of the potent narcotic analgesic (3H)etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 70:1973;1947-1949
449. Simone D.A., Bodnar R.J., Portzline T., Pasternak G.W. Antagonism of morphine analgesia by intracerebroventricular naloxonazine. Pharmacol. Biochem. Behav. 24:1986;1721-1727
450. Sipols A.J., Bayer J., Bennett R., Figlewicz D.P. Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats. Peptides. 23(12):2002;2181-2187
451. Siviy S.M., Bermudez-Rattoni F., Rockwood G.A., Dargie C.M., Reid L.D. Intracerebral administration of naloxone and drinking in water-deprived rats. Pharmacol. Biochem. Behav. 15:1981;257-262
452. Siviy S.M., Reid L.D. Endorphinergic modulation of acceptability of putative reinforcers. Appetite. 4:1983;249-257
453. Soderpalm A.H., Berridge K.C. Food intake after diazepam morphine or muscimol: microinjections in the nucleus accumbens shell. Pharmacol. Biochem. Behav. 66:2000;429-434
454. Spanagel R., Almeida O.F.X., Shippenberg T.S. Evidence that nor-binaltorphamine can function as an antagonist at multiple opioid receptor subtypes. Eur. J. Pharmacol. 264:1994;157-162
455. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1739
456. Spencer R.L., Deupree D., Hsiao S., Mosberg H.I., Hruby V., Burks T.F., et al. Centrally-administered opioid selective agonists inhibit drinking in the rat. Pharmacol. Biochem. Behav. 25:1986;77-82
457. Standifer K.M., Chien C.C., Wahlstedt C., Brown G.P., Pasternak G.W. Selective loss of delta opioid analgesia and binding by oligodeoxynucleotides to a delta opioid receptor. Neuron. 12:1994;805-810
458. Standifer K.M., Jenab S., Su W., Chien C.-C., Pan Y.-X., Inturrisi C.E., et al. Antisense oligodeoxynucleotides to the cloned receptor, DOR-1: uptake, stability and regulation of gene expression. J. Neurochem. 65:1995;1981-1987
459. Standifer K.M., Rossi G.C., Pasternak G.W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol. Pharmacol. 50:1996;293-298
460. Stanley B.G., Lanthier D., Leibowitz S.F. Multiple brain sites sensitive to feeding stimulation by opioid agonists: a cannula-mapping study. Pharmacol. Biochem. Behav. 31:1989;825-832
461. Stein E.A., Carr K.D., Simon E.J. Brain stimulation-induced feeding alters regional opioid receptor binding in the rat: an in vivo autoradiographic study. Brain Res. 533:1990;213-222
462. Stein J.A., Znamensky V., Baumer F., Rossi G.C., Pasternak G.W., Bodnar R.J. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats. Brain Res. 864:2000;240-251
463. Stratford T.R., Holahan M.R., Kelley A.E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport. 8:1997;423-426
464. Stratford T.R., Kelley A.E. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. J. Neurosci. 17:1997;4434-4440
465. Stratford T.R., Swanson C.J., Kelley A.E. Specific changes in food intake elicited by blockade or activation of glutamate receptors in the nucleus accumbens shell. Behav. Brain Res. 93:1998;43-50
466. Summy-Long J.Y., Rosella L.M., Keil L.C. Effects of centrally administered endogenous opioid peptides on drinking behavior, increased plasma vasopressin concentration and pressor response to hypertonic sodium chloride. Brain Res. 221:1981;343-357
467. Svingos A.L., Clarke C.L., Pickel V.M. Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell: relationship with met5-enkephalin. J. Neurosci. 18:1998;1923-1933
468. Svingos A.L., Clarke C.L., Pickel V.M. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization. Synapse. 34:1999;1-10
469. Svingos A.L., Colago E.E., Pickel V.M. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci. 19:1999;1804-1813
470. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin. J. Neurosci. 16:1996;4162-4173
471. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Mu-opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J. Neurosci. 17:1997;2585-2594
472. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol. Biochem. Behav. 58:1997;933-945
473. Takahashi H., Motomatsu T., Nawata H., Kato K., Ibayashi H., Nobunaga M. Influences of feeding and drinking on circadian rhythms of opioid peptides in plasma, hypothalamus and pituitary gland in rats. Physiol. Behav. 37:1986;609-614
474. Takahashi H., Motomatsu T., Nobunaga M. Influences of water deprivation and fasting on hypothalamic, pituitary and plasma opioid peptides and prolactin in rats. Physiol. Behav. 37:1986;603-608
475. Takemori A.E., Larson D.L., Portoghese P.S. The irreversible narcotic antagonist and reversible agonistic properties of the fumarate methyl ester derivative of naltrexone. Eur. J. Pharmacol. 70:1981;445-451
476. Tanda G., DiChiara G. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and the non-psychostimulant drugs of abuse. Eur. J. Neurosci. 10:1998;1179-1187
477. Tang A.H., Collins R.J. Behavioral effects of a novel kappa opioid analgesic, U50488, in rats and rhesus monkeys. Psychopharmacology. 85:1985;309-314
478. Tepperman F.S., Hirst M. Concerning the specificity of the hypothalamic opiate receptor responsible for food intake in the rat. Pharmacol. Biochem. Behav. 17:1982;1141-1144
479. Tepperman F.S., Hirst M. Effects of intrahypothalamic injection of D-Ala-2, D-Leu-5-enkephalin on feeding and temperature in the rat. Eur. J. Pharmacol. 96:1983;243-249
480. Tepperman F.S., Hirst M., Gowdey C.W. Hypothalamic injection of morphine: feeding and temperature responses. Life Sci. 28:1981;2459-2467
481. Terenius L. Stereospecific interaction between narcotic analgesia and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. 32:1973;317-320
482. Thornhill J.A., Hirst M., Gowdey C.W. Disruption of diurnal feeding patterns of rats by heroin. Pharmacol. Biochem. Behav. 4:1976;129-135
483. Thornhill J.A., Hirst M., Gowdey C.W. Tolerance and evidence of physical dependence to daily codeine injections in the rat. Pharmacol. Biochem. Behav. 9:1978;433-438
484. Thornhill J.A., Saunders W. Acute stimulation of feeding with repeated injections of morphine sulphate to non-obese and fatty Zuker rats. Prog. Neuropsychopharmacol. Biol. Psychiat. 7:1983;477-485
485. Thornhill J.A., Saunders W. Ventromedial and lateral hypothalamic injections of naloxone or naltrexone suppress the acute food intake of food-deprived rats. Appetite. 5:1984;25-30
486. Thornhill J.A., Taylor B., Marshall W., Parent K. Central as well as peripheral naloxone administration suppresses feeding in food-deprived Sprague-Dawley and genetically obese (Zucker) rats. Physiol. Behav. 29:1982;841-846
487. Tsujii S., Nakai Y., Fukata J., Koh T., Takahashi H., Usui T., et al. Effects of food deprivation and high fat diet on opioid receptor binding in rat brain. Neurosci. Lett. 72:1986;169-173
488. Tsujii S., Nakai Y., Koh T., Takahashe H., Usui T., Ikeda H., et al. Effects of food deprivation on opioid receptor binding in the brain of lean and fatty Zucker rats. Brain Res. 399:1986;200-203
489. Turkish S., Cooper S.J. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests. Pharmacol. Biochem. Behav. 21:1984;47-51
490. Ueda H., Misawa H., Fukushima N., Katada T., Ui M., Satoh M. A subtype of kappa-opioid receptor mediates inhibition of high-affinity GTPase inherent in Gi1 in guinea pig cerebellar membranes. J. Neurochem. 66:1996;845-851
491. Uhl G.R., Childers S.R., Pasternak G.W. An opiate receptor gene family reunion. Trends Neurosci. 17:1994;89-93
492. Ukai M., Holtzman S.G. Suppression of deprivation-induced water intake by opioid antagonists: central sites of action. Psychopharmacology. 91:1987;279-284
493. Ukai M., Holtzman S.G. Effects of beta-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153:1988;161-165
494. Ukai M., Holtzman S.G. Effects of intrahypothalamic administration of opioid peptides selective for mu kappa and delta receptors on different schedules of water intake in rats. Brain Res. 459:1988;275-281
495. Ukai M., Nakayama S., Kameyama T. The opioid antagonist, MR2266, specifically decreases saline intake in the mouse. Neuropharmacology. 27:1988;1027-1031
496. Vaccarino F.J., Mogil J.S., Stinus L. Chronic dopamine antagonism facilitates opiate-induced feeding. J. Psychiat. Neurosci. 20:1995;210-214
497. Vaccarino F.J., Taube M.R. Intra-arcuate opiate actions stimulate GRF-dependent and protein-selective feeding. Peptides. 18:1997;197-205
498. VanBockstaele E.J., Gracy K.N., Pickel V.M. Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/or dynorphin. J. Comp. Neurol. 351:1995;117-133
499. Van Bockstaele E.J., Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 682:1995;215-221
500. Van Bockstaele E.J., Sesack S.R., Pickel V.M. Dynorphin-immunoreactive terminals in the rat nucleus accumbens: cellular sites for modulation of target neurons and interactions with catecholamine afferents. J. Comp. Neurol. 341:1994;1-15
501. Vaswani K.K., Tejwani G.A. Food-deprivation-induced changes in the level of opioid peptides in the pituitary and brain. Life Sci. 38:1986;197-201
502. Wager-Srdar S.A., Gannon M., Levine A.S. The effect of naloxone on nocturnal food intake in female and male rats. Physiol. Behav. 39:1987;669-672
503. Wager-Srdar S.A., Gosnell B.A., Morley J.E., Levine A.S. The effect of opiates and naloxone on food intake in virgin and lactating rats. Pharmacol. Biochem. Behav. 3:1985;345-348
504. Wager-Srdar S., Levine A.S., Morley J.E. Food intake: opioid/purine interactions. Pharmacol. Biochem. Behav. 21:1984;33-38
505. Wahlestedt C. Antisense oligodeoxynucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15:1994;42-46
506. Walker J.M., Katz R.J., Akil H. Behavioral effects of dynorphin (1-13) in the mouse and rat: initial observations. Peptides. 1:1980;341-345
507. Ward B.O., Somerville E.M., Clifton P.G. Intraaccumbens baclofen selectively enhances feeding behavior in the rat. Physiol. Behav. 68:2000;463-468
508. Ward S.J., Portoghese P.S., Takemori A.E. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. J. Pharmacol. Exp. Ther. 220:1982;494-498
509. Welch C.C., Grace M., Billington C.J., Levine A.S. Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine, and deprivation. Am. J. Physiol. 266:1994;R426-R433
510. Welch C.C., Kim E.M., Grace M.K., Billington C.J., Levine A.S. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 721:1996;126-131
511. Weldon D.T., O'Hare E., Cleary J., Billington C.J., Levine A.S. Effect of naloxone on intake of cornstarch, sucrose and polycose diets in restricted and nonrestricted rats. Am. J. Physiol. 270:1996;R1183-R1188
512. Will M.J., Franzblau E.B., Kelley A.E. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J. Neurosci. 23:2003;2882-2888
513. Wilson J.D., Nicklous D.M., Aloyo V.J., Simansky K.J. An orexigenic role for mu-opioid receptors in the lateral parabrachial nucleus. Am. J. Physiol. 285:2003;R1055-R1065
514. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492
515. Wise R.A., Raptis L. Effects of naloxone and pimozide on initiation and maintenance measures of free feeding. Brain Res. 368:1986;62-68
516. Wolgin D.L., Benson H.D. Role of associative and nonassociative mechanisms in tolerance to morphine anorexia. Pharmacol. Biochem. Behav. 39:1991;279-286
517. Wolinsky T.D., Abrahamsen G.C., Carr K.D. Diabetes alters mu and kappa opioid binding in rat brain: comparison with effects of food restriction. Brain Res. 738:1996;167-171
518. Wolinsky T.D., Carr K.D., Hiller J.M., Simon E.J. Effects of chronic food restriction on mu and kappa opioid binding in rat forebrain: a quantitative autoradiographic study. Brain Res. 656:1994;274-280
519. Wolinsky T.D., Carr K.D., Hiller J.M., Simon E.J. Chronic food restriction alters mu and kappa opioid receptor binding in the parabrachial nucleus of the rat: a quantitative autoradiographic study. Brain Res. 706:1996;333-336
520. Wolozin B.L., Pasternak G.W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 78:1981;6181-6185
521. Woods J.S., Leibowitz S.F. Hypothalamic sites sensitive to morphine and naloxone: effects on feeding behavior. Pharmacol. Biochem. Behav. 23:1985;431-438
522. Yeomans M.R., Gray R.W. Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect. Physiol. Behav. 62:1997;15-21
523. Yeomans M.R., Gray R.W. Opioid peptides and the control of human ingestive behaviour. Neurosci. Biobehav. Rev. 26(6):2002;713-728
524. Yirmaya R., Lieblich I., Liebeskind J.C. Reduced saccharin preference in CXBK (opioid receptor-deficient) mice. Brain Res. 438:1988;339-342
525. Yoshida Y., Koide S., Hirose N., Takada K., Tomiyama K., Koshikawa N., et al. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mu- and delta-2 opioid receptors. Neuroscience. 92:1999;1357-1365
526. Yu W.-Z., Bodnar R.J. Interactions between angiotensin II and delta opioid receptor subtype agonists upon water intake in rats. Peptides. 18:1997;241-245
527. Yu W.-Z., Ruegg H., Bodnar R.J. Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects. Pharmacol. Biochem. Behav. 56:1997;353-361
528. Yu W.-Z., Sclafani A., Delamater A.R., Bodnar R.J. Pharmacology of flavor preference conditioning in sham-feeding rats: effects of naltrexone. Pharmacol. Biochem. Behav. 64:1999;573-584
529. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 386:1997;499-502
530. Zahm D.S., Zaborszky L., Alones V.E., Heimer L. Evidence for the coexistence of glutamate decarboxylase and met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum. Brain Res. 325:1985;317-321
531. Zhang M., Balmadrid C., Kelley A.E. Nucleus accumbens opioid, GABAergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. Behav. Neurosci. 117:2003;202-211
532. Zhang M., Gosnell B.A., Kelley A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J. Pharmacol. Exp. Ther. 285:1998;908-914
533. Zhang M., Kelley A.E. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats. Psychopharmacology. 132:1997;350-360
534. Zhang M., Kelley A.E. Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression. Neuroscience. 99:2000;267-277
535. Zhang M., Kelley A.E. Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology. 159(4):2002;415-423
536. Znamensky V., Echo J.A., Lamonte N., Christian G., Ragnauth A., Bodnar R.J. GABA receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens. Brain Res. 906:2001;84-91
537. Zukin R.S., Eghbalai M., Olive D., Unterwald E.M., Tempel A. Characterization and visualization of rat and guinea pig brain K opioid receptors: evidence for K-1 and K-2 opioid receptors. Proc. Natl. Acad. Sci. U.S.A. 85:1988;4061-4065